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Are antibiotics effective 
in preventing pneumonia 
for nursing home patients?
■ EVIDENCE-BASED ANSWER
Antibiotics should not be used for prophylaxis of
pneumonia in nursing homes. We found no stud-
ies testing the effectiveness of antibiotics in pre-
venting pneumonia in any population, including
persons with predisposing conditions such as
influenza. Three measures effectively prevent
pneumonia in nursing home patients: influenza
vaccination of residents (strength of recommen-
dation [SOR]: B, based on systematic review of
homogenous cohort observational studies);
influenza vaccination of caregivers (SOR: B,
based on individual randomized controlled trial);
pneumococcal vaccination of residents (SOR: B,
based on randomized, nonblinded clinical trials
and consistent case-control studies).
Two other suggested interventions have not
been extensively tested: antiviral chemoprophy-
laxis during an influenza outbreak in the nursing
home, and oral hygiene programs for nursing
home residents.
■ EVIDENCE SUMMARY
Overuse of antibiotics is already a problem in
nursing homes. A large portion of bacterial pneu-
monia in the nursing home population results
from aspiration of oropharyngeal bacteria, which
is more likely to be drug-resistant if the resident
has been on antibiotics.1 We found no studies that
testing antibacterial agents for prevention of
pneumonia in nursing home patients. However,
3 measures are clearly helpful in preventing
pneumonia in nursing home patients: 
1) Influenza vaccination of residents: A meta-
analysis of 20 cohort studies showed a 53% 
efficacy (95% confidence interval [CI], 35–66)—
defined as 1 minus the odds ratio—for influenza
immunization in preventing pneumonia.2
2) Influenza vaccination of caregivers: A cluster
randomized trial in British long-term care facili-
ties demonstrated that influenza vaccination of
health care workers (61% of 1078 workers)
reduced the total nursing home mortality rate
(odds ratio [OR]=0.56 [95% CI, 0.4–0.8]) for a
drop in mortality rate from 17% to 10% (number
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Oral hygiene programs for nursing home resi-
dents may also reduce pneumonia. In a single
study, 366 patients in 11 Japanese nursing homes
were divided into controls (self-care) and those
treated with rigorous oral care (by staff). The
intervention group had a relative risk of 0.6 (95%
CI, 0.36–0.99; NNT=12.5) for pneumonia over a
2-year period.7 The NNT for preventing a death by
pneumonia was 11 (P<.01). This intriguing result
merits follow up in larger groups in US nursing
homes to see if this approach is feasible.
■ RECOMMENDATIONS FROM OTHERS
There are no recommendations about the use of
antibiotic prophylaxis for pneumonia in either the
nursing home or in the outpatient settings; 
however, there are clear recommendations
against the overuse of antibiotics.8
The CDC Advisory Committee on Immunization
needed to treat [NNT]=14.3).3
3) Pneumococcal vaccination of residents: This
evidence was reviewed in a prior Clinical
Inquiry.4 The evidence comes primarily from 
2 clinical trials in which the NNT to prevent 
1 episode of pneumonia was about 35.
Two other proposed interventions require fur-
ther study to evaluate their role in prophylaxis.
Antiviral prophylaxis to prevent pneumonia dur-
ing nursing home outbreaks of influenza has not
been evaluated in controlled trials. Observational
studies strongly suggest that amantadine,
rimantadine, and oseltamivir are all effective in
reducing spread of influenza during outbreaks in
nursing homes (Table). Oseltamivir acts against
influenza B as well as A and has fewer side
effects, but it is more expensive.5,6 Presumably,
decreasing the rate of influenza also reduces the
rate of subsequent pneumonia.
TA B L E
Available treatment 
and prophylactic regimens for influenza
Regimen Regimen 
Drug name for treatment* for prophylaxis† Comments Cost‡
Oseltamivir 75 mg orally 75 mg orally Influenza A and B 10 tabs $59.99
(Tamiflu) twice daily once daily (no generic)
for 5 days for >7 days
Rimantidine 100 mg orally 100 mg orally Influenza A only 14 tabs $33.45
(Flumadine) twice daily twice daily (no generic )
(100 mg orally (100 mg orally 
once daily in once daily in  
elderly) elderly)
Amantadine 100 mg orally 100 mg orally Influenza A only 60 tabs 
(Symmetrel) twice daily twice daily (consider lower $75.58 (brand),
(100 mg orally (100 mg orally doses $18.99 
once daily in once daily  in debilitated (generic)
elderly) in elderly) patients)
Zanamivir 2 inhalations Not indicated Influenza A and B 20 inhalation 
(Relenza) (10 mg) every (inhalations may be doses  $54.41
12 hours for difficult to administer (no generic)
5 days to debilitated patients)
Source: Epocrates RX: Online and PDA-Based Reference, June 12, 2004.
* Start treatment within 48 hours of onset of symptoms.
† Start prophylaxis immediately or within 48 hours of exposure.
‡ Approximate retail price from www.drugstore.com, June 2004.
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What is the best way 
to evaluate and manage
diarrhea in the febrile infant?
■ EVIDENCE-BASED ANSWER
Routine infant diarrhea requires no lab work or
cultures (strength of recommendation [SOR]: C);
the degree of dehydration can be determined 
reliably by percent body weight change (SOR: B).
However, bicarbonate may help rule out dehydra-
tion (SOR: B); electrolytes and blood urea nitro-
gen may be useful in evaluating complicated diar-
rhea with severe dehydration or when intravenous
fluids are required; stool cultures are indicated for
bloody or prolonged diarrhea, suspected food 
poisoning, or recent travel abroad (SOR: C). 
Oral rehydrating solution is adequate fluid
replacement for diarrhea associated with mild 
to moderate dehydration, followed by prompt
refeeding with an age-appropriate diet (SOR: A);
intravenous fluids are recommended for severe
Practices (ACIP) recommends:
• annual influenza vaccine for persons residing
in nursing homes9
• annual influenza vaccine for health care
workers in long-term care facilities9
• pneumococcal vaccine for persons residing in
a nursing home (the schedule for an immuno-
competent adult is a single dose, followed by a
booster after age 65 if the first dose was before
age 65, or after 5 years for persons <65 years
with compromised immune status)10
• chemoprophylaxis for influenza outbreaks in
nursing homes.11
David R. Mouw, MD, PhD, John P. Langlois, MD,
MAHEC Family Practice Residency Program, Asheville, NC,
Department of Family Medicine, University of North Carolina
at Chapel Hill; Linda F. Turner, MSLS, MAHEC Health
Sciences Library, Asheville, NC
■ CLINICAL COMMENTARY
Prevention is key for reducing
pneumonia mortality
Pneumonia is one of the most common causes
of death for nursing home patients. While pneu-
monia can present with the classic fever, pro-
ductive cough, and air hunger, it often presents
with such nonspecific findings as altered mental
status or mild tachypnea, which can significant-
ly delay diagnosis. Additionally, many older
adults poorly tolerate the metabolic demands of
the disease and become critically ill very rapid-
ly. Thus, prevention remains a key strategy for
reducing mortality. Nursing home policies that
facilitate vaccination and reduce disease trans-
mission are critically important in this regard.    
Jon O. Neher, MD, Valley Medical Center, Renton, Wash
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